SMI
11.830,77
PKT
+139,64
PKT
+1,19
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.22 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 28.10.22 | Swiss Re Sector Perform | RBC Capital Markets | |
| 28.10.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 28.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | UBS Outperform | Credit Suisse Group | |
| 27.10.22 | UBS Hold | Jefferies & Company Inc. | |
| 27.10.22 | UBS Sell | Goldman Sachs Group Inc. | |
| 27.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | Novartis Sell | Deutsche Bank AG | |
| 27.10.22 | Holcim Hold | Deutsche Bank AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 26.10.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.22 | UBS Underweight | Barclays Capital | |
| 26.10.22 | Novartis Underweight | Barclays Capital | |
| 26.10.22 | UBS Buy | Deutsche Bank AG | |
| 26.10.22 | UBS Outperform | RBC Capital Markets | |
| 25.10.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 25.10.22 | UBS Buy | Jefferies & Company Inc. | |
| 25.10.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 25.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Sell | Deutsche Bank AG | |
| 25.10.22 | UBS Outperform | RBC Capital Markets | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 25.10.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 25.10.22 | UBS Buy | Jefferies & Company Inc. | |
| 25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
| 24.10.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 24.10.22 | UBS Underweight | Barclays Capital | |
| 24.10.22 | UBS Underweight | Barclays Capital | |
| 24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.10.22 | Givaudan Underperform | Bernstein Research | |
| 21.10.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 21.10.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 21.10.22 | Zurich Insurance Overweight | Barclays Capital | |
| 21.10.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 21.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.